|
Market Cap (21-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 31 August 2021, 8:12. The announcement is not marked as price sensitive, and is 68 page(s) in length and 9.79MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.017% short sold according to ASIC data. It was ranked the 544th most shorted stock on the ASX. It remains ranked 544th as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Annual Report to shareholders | 31 August 2021, 8:12 |
| MDC Receives Approval for NanaBis PIII Trials from the TGA | 25 August 2021, 9:15 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 30 July 2021, 10:06 |
| US Patent Office issues Notice of Allowance for NRGBiotic | 27 July 2021, 9:03 |
You must be logged in to post a reply.
Medlab Clinical 